Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
39
Number of overlapping holdings
45.9%
% of SBIO's 90 holdings also in XBI
33.1%
% of XBI's 119 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 4.3% | 1.1% | 1.1% |
 |
AVIDITY BIOSCIENCES INC | 3.3% | 1.1% | 1.1% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.4% | 0.9% | 0.9% |
|
CRINETICS PHARMACEUTICALS INC | 2.6% | 0.8% | 0.8% |
|
AKERO THERAPEUTICS, INC. | 3.0% | 0.8% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to XBI
|
AXSOME THERAPEUTICS, INC. | 4.2% |
|
ALKERMES PLC | 3.2% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.8% |
|
PTC THERAPEUTICS INC | 2.7% |
 |
MERUS N.V. | 2.6% |
|
RHYTHM PHARMACEUTICALS, INC. | 2.6% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 2.3% |
|
AKERO THERAPEUTICS, INC. | 2.3% |
|
AVIDITY BIOSCIENCES INC | 2.2% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.0% |
SBIO Underweight Relative to XBI
|
EXACT SCIENCES CORP | -2.8% |
|
NATERA INC | -2.7% |
|
ALNYLAM PHARMACEUTICALS INC | -2.7% |
|
VERTEX PHARMACEUTICALS INC | -2.5% |
|
NEUROCRINE BIOSCIENCES INC | -2.5% |
|
INSMED INC | -2.5% |
|
BLUEPRINT MEDICINES CORP. | -2.4% |
|
UNITED THERAPEUTICS CORP | -2.4% |
|
ABBVIE INC | -2.4% |
|
INCYTE CORP | -2.3% |